EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Acid-Stabilizing Hemagglutinin Mutations on Immunogenicity and Heterologous Protection by H1N1 Influenza Virus mRNA-LNP Vaccines

Chet R Ojha, Samuel W Rovito iD, Balaji Banoth, Hyunsuh Kim, Jeremy C Jones, Mohamad-Gabriel Alameh, Po-Ling Chen iD, Richard J Webby iD, Drew Weissman, Charles J Russell iD

Viruses · 15.04.2026 · 18 (4) · 467

DOI: 10.3390/v18040467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 15.04.2026. Verfasst von Chet R Ojha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: Hemagglutinin Glycoproteins, Influenza Virus, Influenza Vaccines, Influenza A Virus, H1N1 Subtype, Immunogenicity, Vaccine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, ODCDC CDC HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While current influenza vaccines often lack broad protection against antigenically drifted strains, some modified hemagglutinin (HA) protein antigens have shown promise in eliciting broadly neutralizing antibodies against conserved epitopes. During infection, the mildly acidic environment of the late endosome triggers irreversible HA conformational changes resulting in a post-fusion structure with altered antigenicity. While enhancing the stability of other structural class I viral fusion protein antigens has been instrumental in improving the effectiveness of COVID-19 and RSV vaccines, the role of HA stability in influenza vaccine immunogenicity is relatively unclear. Here, we used the nucleoside-modified mRNA-LNP platform to test engineered HA antigens with specific acid-stabilizing mutations (E47K, K58I, R106K, and K153E) in the HA stalk. All mutations increased HA acid stability, but E47K and R106K did not increase immunogenicity. K153E and K58I, but not E47K and R106K, enhanced the cell-surface expression of the HA protein in vitro. In mice, K153E- and K58I-containing mRNA-LNP vaccines elicited increased neutralizing antibody titers against homologous virus. K153E conferred greater protection than wild-type vaccine against lethal heterologous A/PR/8/34 challenge at low doses (0.5–1.0 µg), despite the absence of neutralizing antibodies against the challenge strain. K153E also elicited greater expansion of antigen-specific antibody-secreting cells (ASCs) in the bone marrow, as well as cross-reactive T follicular helper (Tfh) cells in the spleen. For the vaccines studied, increased HA expression was a stronger correlate of mRNA-LNP enhancement than increased HA stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesInfluenza A Virus, H1N1 SubtypeImmunogenicity, VaccineOrthomyxoviridae InfectionsMutationAnimalsAntibodies, ViralMiceAntibodies, NeutralizingFemaleMice, Inbred BALB CNanovaccinesRNA, MessengerImmunity, HeterologousVaccines, Synthetic

Stichwörter der Autor:innen

hemagglutininheterologous protectionimmunogenicityinfluenza vaccinesnucleoside modified mRNA-LNPstalk mutations

Substanzen

Hemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesAntibodies, ViralAntibodies, NeutralizingNanovaccinesRNA, MessengerVaccines, Synthetic

Autor:innen und Institutionen

  • Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • St. Jude Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

ORCID-Profile: Samuel W Rovito, Po-Ling Chen, Richard J Webby, Charles J Russell

Förderung

  • NIAID NIH HHS
  • ODCDC CDC HHS
  • National Institute of Allergy and Infectious Diseases
  • St. Jude Children’s Research Hospital
  • American Lebanese Syrian Associated Charities

Zitieren

APA

Ojha, C. R., Rovito, S. W., Banoth, B., Kim, H., Jones, J. C., Alameh, M. G., Chen, P. L., Webby, R. J., Weissman, D., & Russell, C. J. (2026). Effect of Acid-Stabilizing Hemagglutinin Mutations on Immunogenicity and Heterologous Protection by H1N1 Influenza Virus mRNA-LNP Vaccines. Viruses, 18(4), 467. https://doi.org/10.3390/v18040467

Vancouver

Ojha CR, Rovito SW, Banoth B, Kim H, Jones JC, Alameh MG, et al. Effect of Acid-Stabilizing Hemagglutinin Mutations on Immunogenicity and Heterologous Protection by H1N1 Influenza Virus mRNA-LNP Vaccines. Viruses. 2026;18(4):467. doi:10.3390/v18040467

BibTeX
@article{Ojha2026,
  author = {Ojha, Chet R and Rovito, Samuel W and Banoth, Balaji and Kim, Hyunsuh and Jones, Jeremy C and Alameh, Mohamad-Gabriel and Chen, Po-Ling and Webby, Richard J and Weissman, Drew and Russell, Charles J},
  title = {Effect of Acid-Stabilizing Hemagglutinin Mutations on Immunogenicity and Heterologous Protection by H1N1 Influenza Virus mRNA-LNP Vaccines},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {467},
  doi = {10.3390/v18040467}
}
Kostenlos starten →